IL4 and myeloid sarcoma: Peripheral blood mononuclear cells expressing IL-4 have been shown to be significantly elevated in MS exacerbations and progressive MS over controls [66] but also found to be decreased alongside IFN-γ in active and stable MS compared to controls [67].